Here are four key points on the stock rise, according to the report:
1. Yesterday’s trading marks AmSurg’s market cap at $3.31 billion.
2. The company’s P/E ratio is 61.
3. Volume on the 52-week high was 309,118, and the stock has a float of 48.41 million shares, averaging a daily volume of $397,081.
4. AmSurg employs roughly 10,500 people under CEO Christopher A. Holden.
More articles on transactions and valuation issues:
7 things to know about Q1 healthcare M&A
MFC announce normal course issuer bid approval
The Children’s Hospital of Philadelphia officially opens ASC: 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.